Yifeng Pharmacy Chain Co., Ltd. (SHA: 603939)

Yifeng Pharmacy Chain Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,228	3,566	4,113	2,921	3,360	1,424
Short-Term Investments	-	-	-	-	4	47.29
Trading Asset Securities	4,829	1,631	50.05	152.19	744.84	193.23
Cash & Short-Term Investments	8,057	5,197	4,163	3,073	4,109	1,665
Cash Growth	75.13%	24.84%	35.46%	-25.22%	146.79%	4.89%
Accounts Receivable	1,713	2,150	1,846	1,087	831.17	750.98
Other Receivables	411.02	448.54	419.47	323.6	207.6	202
Receivables	2,124	2,599	2,265	1,411	1,039	952.99
Inventory	3,897	3,808	3,615	3,041	2,172	1,821
Prepaid Expenses	-	-	-	35.17	-	-
Other Current Assets	595.57	525.62	535.91	356.71	341.71	547.46
Total Current Assets	14,675	12,129	10,578	7,916	7,662	4,986
Property, Plant & Equipment	5,951	5,665	4,892	4,504	3,550	527.95
Long-Term Investments	526.67	592.97	334.09	6.72	6.72	30.79
Goodwill	4,794	4,611	4,188	3,718	3,338	3,045
Other Intangible Assets	454.36	470.97	478.2	389.25	370.68	345.77
Long-Term Deferred Tax Assets	194.23	138.67	127.68	109.79	74.15	20.61
Long-Term Deferred Charges	592.37	499.14	430.69	379.59	267.45	206.97
Other Long-Term Assets	24.14	30.27	7.23	28.39	58.37	12.21
Total Assets	27,212	24,137	21,036	17,052	15,327	9,175
Accounts Payable	8,827	8,171	6,761	4,806	3,822	3,019
Accrued Expenses	364.75	660.66	683.11	390	332.21	296.78
Short-Term Debt	20	-	-	-	380.32	29.3
Current Portion of Long-Term Debt	1,576	103.48	92.92	4.21	58.9	58.9
Current Portion of Leases	-	1,355	1,185	931.44	748.43	-
Current Income Taxes Payable	274.72	165.76	176.87	148.83	78.14	50.5
Current Unearned Revenue	77.2	80.17	60.69	41.1	30.54	-
Other Current Liabilities	1,147	733.46	700.13	424.11	416.39	270.67
Total Current Liabilities	12,287	11,269	9,659	6,745	5,867	3,725
Long-Term Debt	1,662	133.62	228.67	365.65	1,976	687.15
Long-Term Leases	2,293	2,206	1,951	2,024	1,766	-
Long-Term Unearned Revenue	53.76	54.09	54.69	50.34	51.46	51.43
Long-Term Deferred Tax Liabilities	16.53	26.76	23.71	2.16	2.41	2.69
Total Liabilities	16,312	13,689	11,917	9,187	9,664	4,466
Common Stock	1,212	1,011	721.7	718.77	531.52	378.92
Additional Paid-In Capital	3,651	3,716	3,991	3,988	2,594	2,654
Retained Earnings	5,275	4,973	3,849	2,802	2,080	1,535
Treasury Stock	-38.61	-42.24	-77.41	-27.76	-63.02	-60.53
Comprehensive Income & Other	153.61	147.93	68.34	-	215.67	-
Total Common Equity	10,253	9,804	8,553	7,481	5,359	4,508
Minority Interest	646.63	642.66	565.39	383.24	304.81	200.67
Shareholders' Equity	10,900	10,447	9,119	7,865	5,663	4,709
Total Liabilities & Equity	27,212	24,137	21,036	17,052	15,327	9,175
Total Debt	5,550	3,798	3,458	3,325	4,930	775.35
Net Cash (Debt)	2,507	1,399	705.02	-252.57	-821.45	889.66
Net Cash Growth	146.55%	98.44%	-	-	-	11.44%
Net Cash Per Share	2.07	1.16	0.58	-0.21	-0.71	0.77
Filing Date Shares Outstanding	1,212	1,213	1,212	1,208	1,208	1,159
Total Common Shares Outstanding	1,212	1,213	1,212	1,208	1,161	1,159
Working Capital	2,387	859.44	918.95	1,171	1,795	1,261
Book Value Per Share	8.46	8.08	7.05	6.20	4.62	3.89
Tangible Book Value	5,005	4,723	3,887	3,374	1,650	1,118
Tangible Book Value Per Share	4.13	3.89	3.21	2.79	1.42	0.96
Buildings	-	1,291	1,004	683.76	415.71	296.43
Machinery	-	1,001	843.34	722.34	546.17	457.28
Construction In Progress	-	175.12	239.85	358.64	235.87	84.42

Source: S&P Capital IQ. Standard template. Financial Sources.